Source: Annual Congress 2002 - Sleep apnoea as a systemic disease
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
T. Bratel, M. Axelson, K. Carlström, A. Wennlund, T. Andersson (Stockholm, Huddinge, Sweden). Cortisol metabolism in obstructive sleep apnea (OSA). Eur Respir J 2002; 20: Suppl. 38, 1420

Member's Comments

No comment yet.

Related content which might interest you: Catecholamine secretion in obstructive sleep apnoea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 Screening for obstructive sleep apnea (OSA) in acromegaly Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020 Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006 Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Hyperuricaemia in females with obstructive sleep apnoea (OSA) Source: Eur Respir J 2003; 22: Suppl. 45, 91s Year: 2003 Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Erythrocyte glycolysis in severe obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Hyperuricaemia in males with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Obesity, obstructive sleep apnea (OSA) and asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Prevalence of nocturia in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 646s Year: 2006 The role of angiogenesis in obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010